Stock listing
A40ZYR Stock Price, News, Filings & Events — Ascentage Pharma Group International
Selected listing: A40ZYR · LS · EUR · DE
This page tracks Ascentage Pharma Group International's A40ZYR:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40ZYR:LS. A40ZYR:LS is the stock-level entry point for investors researching Ascentage Pharma Group International, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A40ZYR:LS
- Asset type
- Stock
- Market cap
- $1.59B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Ascentage Pharma Group International A40ZYR:LS stock context
This page tracks Ascentage Pharma Group International's A40ZYR:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A40ZYR:LS. A40ZYR:LS is the stock-level entry point for investors researching Ascentage Pharma Group International, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ascentage Pharma Group International
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
August 5, 2026
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
August 5, 2026
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
July 26, 2026
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
June 14, 2026
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
May 31, 2026
Ascentage Pharma Group International earnings calls
Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call
August 20, 2026 · Replay with transcript and chapters
Ascentage Pharma Group International (AAPG) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Ascentage Pharma Group International (AAPG) Q2 2025 Earnings Call
August 21, 2025 · Replay with transcript and chapters
Research Ascentage Pharma Group International
Ascentage Pharma Group International investor report
Review AI stock analysis and investor report context for A40ZYR:LS.
Ascentage Pharma Group International company profile
View the public company page for Ascentage Pharma Group International on 6ix.
Ascentage Pharma Group International news
Read company news and market updates connected to Ascentage Pharma Group International.
Ascentage Pharma Group International investor events
Find investor webinars, events, and replay context for Ascentage Pharma Group International.
Alternate listings
6855:HKEX
HK · HKD
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
AAPG:NASDAQ
US · USD
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
ASPHF:OTC
US · USD
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
A2PUCQ:LSX
DE · EUR
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
A2PUCQ:LS
DE · EUR
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
AAPG:BOATS
US · USD
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
36X0:DUS
DE · EUR
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
36X:FWB
DE · EUR
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
36X0:FWB
DE · EUR
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
A40ZYR:LSX
DE · EUR
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
36X:SWB
DE · EUR
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.
36X0:SWB
DE · EUR
Alternate listing for Ascentage Pharma Group International; the primary context on this page is A40ZYR:LS.